Weishaar KM - Search Results

1

Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma.

Gustafson DL, Collins KP, Fowles JS, Ehrhart EJ, Weishaar KM, Das S, Duval DL, Thamm DH. Gustafson DL, et al. Among authors: weishaar km. Cancer Chemother Pharmacol. 2021 Oct;88(4):699-712. doi: 10.1007/s00280-021-04325-y. Epub 2021 Jul 14. Cancer Chemother Pharmacol. 2021. PMID: 34263337

2

Vinorelbine rescue therapy for dogs with primary urinary bladder carcinoma.

Kaye ME, Thamm DH, Weishaar K, Lawrence JA. Kaye ME, et al. Vet Comp Oncol. 2015 Dec;13(4):443-51. doi: 10.1111/vco.12065. Epub 2013 Aug 25. Vet Comp Oncol. 2015. PMID: 23981116

3

Malignant mesenchymoma with widespread metastasis including bone marrow involvement in a dog.

Weishaar KM, Edmondson EF, Thamm DH, Olver CS. Weishaar KM, et al. Vet Clin Pathol. 2014 Sep;43(3):447-52. doi: 10.1111/vcp.12180. Epub 2014 Jul 30. Vet Clin Pathol. 2014. PMID: 25132008

4

Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis.

Weishaar KM, Thamm DH, Worley DR, Kamstock DA. Weishaar KM, et al. J Comp Pathol. 2014 Nov;151(4):329-38. doi: 10.1016/j.jcpa.2014.07.004. Epub 2014 Aug 27. J Comp Pathol. 2014. PMID: 25172053

5

Expression of Phosphorylated KIT in Canine Mast Cell Tumor.

Halsey CHC, Thamm DH, Weishaar KM, Burton JH, Charles JB, Gustafson DL, Avery AC, Ehrhart EJ. Halsey CHC, et al. Among authors: weishaar km. Vet Pathol. 2017 May;54(3):387-394. doi: 10.1177/0300985816688943. Epub 2017 Jan 27. Vet Pathol. 2017. PMID: 28129097

6

c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine.

Weishaar KM, Ehrhart EJ, Avery AC, Charles JB, Elmslie RE, Vail DM, London CA, Clifford CA, Eickhoff JC, Thamm DH. Weishaar KM, et al. J Vet Intern Med. 2018 Jan;32(1):394-405. doi: 10.1111/jvim.14889. Epub 2017 Nov 30. J Vet Intern Med. 2018. PMID: 29194765 Free PMC article. Clinical Trial.

7

NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.

Burton JH, Mazcko C, LeBlanc A, Covey JM, Ji J, Kinders RJ, Parchment RE, Khanna C, Paoloni M, Lana S, Weishaar K, London C, Kisseberth W, Krick E, Vail D, Childress M, Bryan JN, Barber L, Ehrhart EJ, Kent M, Fan T, Kow K, Northup N, Wilson-Robles H, Tomaszewski J, Holleran JL, Muzzio M, Eiseman J, Beumer JH, Doroshow JH, Pommier Y. Burton JH, et al. Clin Cancer Res. 2018 Dec 1;24(23):5830-5840. doi: 10.1158/1078-0432.CCR-18-1498. Epub 2018 Jul 30. Clin Cancer Res. 2018. PMID: 30061364 Free PMC article.

8

Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers.

Wittenburg LA, Weishaar K, Ramirez D, Gustafson DL. Wittenburg LA, et al. Vet Comp Oncol. 2019 Jun;17(2):147-154. doi: 10.1111/vco.12455. Epub 2019 Feb 4. Vet Comp Oncol. 2019. PMID: 30638304 Free PMC article.

9

Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.

Thamm DH, Weishaar KM, Charles JB, Ehrhart EJ 3rd. Thamm DH, et al. Among authors: weishaar km. Vet Comp Oncol. 2020 Jun;18(2):169-175. doi: 10.1111/vco.12525. Epub 2019 Oct 21. Vet Comp Oncol. 2020. PMID: 31365175

10

Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma.

Thamm DH, Joseph JK, Rose BJ, Meuten TK, Weishaar KM. Thamm DH, et al. Among authors: weishaar km. BMC Vet Res. 2020 Mar 24;16(1):97. doi: 10.1186/s12917-020-02317-3. BMC Vet Res. 2020. PMID: 32209084 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page